Trial updateOphthalmology
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Recruiting. Phase 3. Registered enrolment: 426. Jaeb Center for Health Research
Why it matters
Track this study through NCT06790784. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 3
- Registered enrolment
- 426
- Results posted
- No
- Sponsor
- Jaeb Center for Health Research
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.